Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
Abstract Standard of care for Epithelial Ovarian Cancer (EOC) patients relies on platinum-based therapy. However, acquired resistance to platinum occurs frequently and predicts poor prognosis. To understand the mechanisms underlying acquired platinum-resistance, we have generated and characterized t...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8bf1a13f3ec742d7ba5ce35739f9999f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8bf1a13f3ec742d7ba5ce35739f9999f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8bf1a13f3ec742d7ba5ce35739f9999f2021-12-02T12:32:14ZCommon biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells10.1038/s41598-017-07005-12045-2322https://doaj.org/article/8bf1a13f3ec742d7ba5ce35739f9999f2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07005-1https://doaj.org/toc/2045-2322Abstract Standard of care for Epithelial Ovarian Cancer (EOC) patients relies on platinum-based therapy. However, acquired resistance to platinum occurs frequently and predicts poor prognosis. To understand the mechanisms underlying acquired platinum-resistance, we have generated and characterized three platinum-resistant isogenic EOC cell lines. Resistant cells showed 3-to 5- folds increase in platinum IC50. Cross-resistance to other chemotherapeutic agents commonly used in the treatment of EOC patients was variable and dependent on the cell line utilized. Gene expression profiling (GEP) of coding and non-coding RNAs failed to identify a common signature that could collectively explain the mechanism of resistance. However, we observed that all resistant cell lines displayed a decreased level of DNA platination and a faster repair of damaged DNA. Furthermore, all platinum resistant cell lines displayed a change in their morphology and a higher ability to grown on mesothelium. Overall, we have established and characterized three new models of platinum-resistant EOC cell lines that could be exploited to further dissect the molecular mechanisms underlying acquired resistance to platinum. Our work also suggests that GEP studies alone, at least when performed under basal culture condition, do not represent the optimal way to identify molecular alterations linked to DNA repair pathway defects.Maura SonegoIlenia PellizzariAlessandra Dall’AcquaEliana PivettaIlaria LorenzonSara BenevolRiccardo BombenPaola SpessottoRoberto SorioValter GatteiBarbara BellettiMonica SchiappacassiGustavo BaldassarreNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Maura Sonego Ilenia Pellizzari Alessandra Dall’Acqua Eliana Pivetta Ilaria Lorenzon Sara Benevol Riccardo Bomben Paola Spessotto Roberto Sorio Valter Gattei Barbara Belletti Monica Schiappacassi Gustavo Baldassarre Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
description |
Abstract Standard of care for Epithelial Ovarian Cancer (EOC) patients relies on platinum-based therapy. However, acquired resistance to platinum occurs frequently and predicts poor prognosis. To understand the mechanisms underlying acquired platinum-resistance, we have generated and characterized three platinum-resistant isogenic EOC cell lines. Resistant cells showed 3-to 5- folds increase in platinum IC50. Cross-resistance to other chemotherapeutic agents commonly used in the treatment of EOC patients was variable and dependent on the cell line utilized. Gene expression profiling (GEP) of coding and non-coding RNAs failed to identify a common signature that could collectively explain the mechanism of resistance. However, we observed that all resistant cell lines displayed a decreased level of DNA platination and a faster repair of damaged DNA. Furthermore, all platinum resistant cell lines displayed a change in their morphology and a higher ability to grown on mesothelium. Overall, we have established and characterized three new models of platinum-resistant EOC cell lines that could be exploited to further dissect the molecular mechanisms underlying acquired resistance to platinum. Our work also suggests that GEP studies alone, at least when performed under basal culture condition, do not represent the optimal way to identify molecular alterations linked to DNA repair pathway defects. |
format |
article |
author |
Maura Sonego Ilenia Pellizzari Alessandra Dall’Acqua Eliana Pivetta Ilaria Lorenzon Sara Benevol Riccardo Bomben Paola Spessotto Roberto Sorio Valter Gattei Barbara Belletti Monica Schiappacassi Gustavo Baldassarre |
author_facet |
Maura Sonego Ilenia Pellizzari Alessandra Dall’Acqua Eliana Pivetta Ilaria Lorenzon Sara Benevol Riccardo Bomben Paola Spessotto Roberto Sorio Valter Gattei Barbara Belletti Monica Schiappacassi Gustavo Baldassarre |
author_sort |
Maura Sonego |
title |
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
title_short |
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
title_full |
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
title_fullStr |
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
title_full_unstemmed |
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
title_sort |
common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/8bf1a13f3ec742d7ba5ce35739f9999f |
work_keys_str_mv |
AT maurasonego commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT ileniapellizzari commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT alessandradallacqua commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT elianapivetta commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT ilarialorenzon commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT sarabenevol commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT riccardobomben commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT paolaspessotto commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT robertosorio commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT valtergattei commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT barbarabelletti commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT monicaschiappacassi commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells AT gustavobaldassarre commonbiologicalphenotypescharacterizetheacquisitionofplatinumresistanceinepithelialovariancancercells |
_version_ |
1718394170267140096 |